⚠️Great news! @GileadSciences is donating 1.5 million doses of its experimental antiviral drug #remdesivir that could treat 140,000 #COVID19 patients. The drug will be FREE for "compassionate use, expanded access and clinical trials.”
#coronavirus
thehill.com/homenews/49120…
#coronavirus
thehill.com/homenews/49120…
#Remdesivir inhibits viral replication by blocking the ability of the virus to make new copies of its RNA genetic code.
I spent nearly a decade developing a similar drug (galidesivir/BCX4430) to fight #Ebola & other deadly viruses like this #coronavirus.
I spent nearly a decade developing a similar drug (galidesivir/BCX4430) to fight #Ebola & other deadly viruses like this #coronavirus.
Another drug in this same class (RNA-dependent polymerase inhibitor) is #favipiravir, approved in #Japan for the treatment of #influenza (another RNA virus).
Favipiravir reportedly was effective in treating #COVID19, so #remdesivir may also work.😃
Favipiravir reportedly was effective in treating #COVID19, so #remdesivir may also work.😃
Clinical trials are underway to study #remdesivir in #COVID19. This class of antiviral drugs holds substantial promise in our fight against this deadly #coronavirus, because it DIRECTLY attacks the ability of the virus to make new viral particles.😃
